These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 291813)

  • 21. Risk-benefit ratio: hazardous surgery and experimental therapy.
    Rosner F
    Mt Sinai J Med; 1984; 51(1):58-9. PubMed ID: 6369122
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1985 Dec; 8(4):176-80. PubMed ID: 3867980
    [No Abstract]   [Full Text] [Related]  

  • 23. Cross-generational retribution and genetic engineering: reflections on chance and free will.
    Troster L
    Conserv Jud; 2002; 54(3):33-41. PubMed ID: 12735299
    [No Abstract]   [Full Text] [Related]  

  • 24. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 25. The prospect of private unauthorized eugenics and ten feet tall basketball players: a case of legislative oversight?
    Meredith RD
    J Contemp Health Law Policy; 1985; 1(1):155-72. PubMed ID: 11645591
    [No Abstract]   [Full Text] [Related]  

  • 26. Discussions on human gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1986 Jun; 9(2):88-130. PubMed ID: 3532218
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro fertilization and embryo transfer: fertile areas for litigation.
    Lorio KV
    Southwest Law J; 1982 Feb; 35(5):973-1011. PubMed ID: 11658618
    [No Abstract]   [Full Text] [Related]  

  • 28. An expanded partnership with God? In vitro fertilization in Jewish ethics.
    Mackler AL
    J Relig Ethics; 1997; 25(2):277-304. PubMed ID: 11660548
    [No Abstract]   [Full Text] [Related]  

  • 29. Draft report to annual and central conferences, Dec 1990: an invitation to explore a frontier.
    United Methodist Church. Genetic Science Task Force
    Engage Soc Action; 1991 Jan; 4(1):17-27. PubMed ID: 11659313
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotechnology: can a new technology survive?
    Withers WW; Kenworthy PG
    St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic engineering: federal ethics commission hears theologians.
    Nelson JR
    Hosp Prog; 1982 Dec; 63(12):42-7. PubMed ID: 10289366
    [No Abstract]   [Full Text] [Related]  

  • 32. The potential for genetic engineering: a proposal for international legal control.
    Gardner BJ
    VA J Int Law; 1976; 16(2):403-29. PubMed ID: 11661343
    [No Abstract]   [Full Text] [Related]  

  • 33. Summary from "Splicing life": a report on the social and ethical issues of genetic engineering with human beings. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.
    Recomb DNA Tech Bull; 1983 Mar; 6(1):10-2. PubMed ID: 6573728
    [No Abstract]   [Full Text] [Related]  

  • 34. Rabbinic comment: Risk-benefit ratios.
    Tendler MD
    Mt Sinai J Med; 1984; 51(1):60-4. PubMed ID: 6608683
    [No Abstract]   [Full Text] [Related]  

  • 35. The challenge of biotechnology.
    Gore A; Owens S
    Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468
    [No Abstract]   [Full Text] [Related]  

  • 36. On ethics, gyroscopes, and radar sets.
    Morison RS
    Hastings Cent Rep; 1980 Feb; 10(1):26-8. PubMed ID: 7372455
    [No Abstract]   [Full Text] [Related]  

  • 37. The case. What should Leah be told?
    Lantos JD
    Second Opin; 1993 Apr; 18(4):81-6. PubMed ID: 10125419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human gene therapy--playing God?
    Seydel FD
    Prog Clin Biol Res; 1990; 352():339-46. PubMed ID: 2205868
    [No Abstract]   [Full Text] [Related]  

  • 39. The nucleus family.
    Blumenthal S
    Stud Lawyer; 1978 Sep; 7(1):24-27+. PubMed ID: 11662505
    [No Abstract]   [Full Text] [Related]  

  • 40. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.